BioGaia® Gastrus contains Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475, sourced from human origin.
$49.78 incl. GST
BioGaia® Gastrus contains Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475, sourced from human origin.
Targeted support with this unique Lactobacillus reuteri strain combination.
Formulation notes:
- Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk)
- Provides evidence-based probiotic strains with clinical data to support their use.
- Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFUs).
- Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer.
- Ensure only complementary probiotic strains are combined for optimal efficacy.
- Delivers a scientifically validated daily dose of 200 million organisms (CFUs) in a convenient one-a-day dose.
- Does not require refrigeration, for ease of use and convenience.
- Sweetened with xylitol.
| Each BioGaia® Gastrus chewable tablet contains: | |
| Lactobacillus reuteri (DSM 17938) + | 100 million organisms (CFUs) |
| Lactobacillus reuteri (ATCC PTA 6475) | 100 million organisms (CFUs) |
Excipients:
- Isomalt
- Sustainably sourced fully hydrogenated palm oil
- Ascorbic acid
- Calcium stearate
- Mandarin flavouring
- Mint flavouring
- Vegetarian formula.
- No added: wheat, yeast, soy, dairy and animal products, lactose, egg, nuts, artificial colours, flavours, or preservatives, magnesium stearate or SLS.
